Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2014 Mar 3;9(3):e89781. doi: 10.1371/journal.pone.0089781

Sequence Complexity of Amyloidogenic Regions in Intrinsically Disordered Human Proteins

Swagata Das 1, Uttam Pal 1, Supriya Das 1, Khyati Bagga 1, Anupam Roy 1, Arpita Mrigwani 1, Nakul C Maiti 1,*
Editor: Alexandre G de Brevern2
PMCID: PMC3940659  PMID: 24594841

Abstract

An amyloidogenic region (AR) in a protein sequence plays a significant role in protein aggregation and amyloid formation. We have investigated the sequence complexity of AR that is present in intrinsically disordered human proteins. More than 80% human proteins in the disordered protein databases (DisProt+IDEAL) contained one or more ARs. With decrease of protein disorder, AR content in the protein sequence was decreased. A probability density distribution analysis and discrete analysis of AR sequences showed that ∼8% residue in a protein sequence was in AR and the region was in average 8 residues long. The residues in the AR were high in sequence complexity and it seldom overlapped with low complexity regions (LCR), which was largely abundant in disorder proteins. The sequences in the AR showed mixed conformational adaptability towards α-helix, β-sheet/strand and coil conformations.

Introduction

The available genome sequences and several computational methods have revealed a unique presence of some proteins which remain disordered under physiological condition and resemble their own functional states [1][9]. These proteins are known by different names like intrinsically disordered [10], natively denatured [11], natively unfolded protein and intrinsically unstructured proteins [3], [10]. The accepted convention is however intrinsically disordered protein (IDP). It comprises of 25–30% of eukaryotic proteome and ∼50% of eukaryotic proteins contain long disorder regions [12]. The IDPs lack any well-defined three dimensional folded structures in solution and structurally they remain as an ensemble of interconverting conformations under physiological conditions [13][15]. The lack of a rigid and folded stable structure may provide large plasticity to IDPs to interact efficiently with different targets, as compared to a globular protein with limited conformational flexibility [16], [17]. These characteristics possibly aid good efficacy to IDPs to be involved in different pathological and biochemical functions [5], [6], [13], [16], [18][20]. The functional domain varies from DNA binding to cell cycle regulation, membrane transport, different molecular recognition processes, and other important cellular functions [19], [21][23].

In addition to IDPs' important role in cellular activity, the inherited structural disorder plays an important role in the formation of protein assembly structure [24]. The structural disorder and flexibility of IDPs are also linked to formation of amyloid aggregates that is implicated in several human disorder such as Parkinson's disease, Alzheimer's disease, type II diabetes and others [25][30]. The major protein component of fibrillar deposits found in Parkinson's disease is a disordered protein, α-synuclein [25][30]. Alzheimer's disease is directly linked with production of ordered fibrillar structure of peptide Aβ42. Thus several neurological disorders are linked to formation of amyloid fibrils and their deposition in various cellular organs.

However, it is not very clear how normally soluble disordered proteins/peptides are converted into amyloid fibre that possesses compact β-sheet structure. It has been also further observed and presented in many in vitro experiments that some structured proteins convert to amyloid fibrils under solution conditions where the proteins attained partial disordered structure [31], [32]. Experimental study and many computational analyses showed that short sequence stretches in proteins may be responsible and act as nucleating centres for amyloid fibril formation [33][36]. These regions are often known as amyloidogenic regions (ARs). Amyloidogenic sequences of six to eight residues when inserted in the C-terminal hinge loop of RNase A, the enzyme shows amyloidogenicity and forms amyloid fibres [34][36]. Presence of such regions in many water soluble proteins has been suggested by Dobson [36], [37] and others [38]. According to ‘amyloid stretch hypothesis’ [35], a short amyloid stretch (equivalent to AR) in a certain solution condition triggers the aggregation process. Mutation or reshuffling in this regions leads to decrease or total absence of such aggregation [33], [39]. Thus AR often acts as a nucleation center and governs protein aggregation that eventually leads to formation of β sheet rich amyloid fiber.

The IDPs are also rich sequences with biased amino acid residues in a stretch, often known as low complexity regions (LCRs). These regions may also play a critical role in protein stability and energetic of fibril formation [1], [40][47]. LCRs are usually of two types: a majority of LCRs is composed of mixed polar and charged amino acid (aa) residues and the presence of such regions enhances protein solubility and mobility in solution. Second type of LCR is a repeat of one/two sequence which is prone to form amyloid fiber. A good example of such region is a stretch of Glu (polyGlu) [48]. Thus the presence of LCR modulates the solubility and amyloidogenicity of disordered proteins [45], [49], [50].

The composition, content and distribution of ARs and LCRs in a protein sequence, therefore, may have a certain role in protein aggregation and amyloidogenicity. However, no major investigation has been carried out regarding sequence complexity of ARs and their spacing among LCRs which are commonly found in IDP sequences. In the present investigation, we computationally detected and analyzed the sequence composition and complexity, distribution pattern and structural aspects of ARs and LCRs in proteins those are deposited in DisProt and IDEAL databases [4], [50], [51]. About 8% residue is found to be in AR and the average length of the region is 8 residues. Further we have found that the sequences in AR are highly complex and they rarely overlap with LCR.

Among many recently developed computational approaches and algorithms, we have used Waltz method that is developed by Maurer-Stroh et al. [52][56] to predict the ARs. The Waltz algorithm uses a position specific scoring matrix (PSSM) and combined physical properties and structural aspects of protein residues to identify AR [40], [41], [57], [58]. Computation tool SMART is used to predict the sequence complexity parameters. We have measured the structural propensity of the residues in AR by APSSP2 algorithm which is freely available in the World Wide Web [59], [60].

Materials and Methods

Selection of Intrinsically Disordered Proteins

DisProt database release 5.6 (http://www.disprot.org/) provides a set of proteins with different degree of disorderness [4]. It gives the name of the protein, accession codes, aa sequence, location of the disordered region(s), and methods used for structural (disorder) characterization. DisProt analysis also reveals biological function(s) of each disordered regions. Sequences of each protein were retrieved in FASTA format. Length, the aa composition, residue characteristics such as total number of positive and negative residues and theoretical isoelectric point (PI) were computed using the ProtParam tool of ExPASy Proteomic server (http://us.expasy.org/tools/protparam.html). The total charge of the proteins was calculated by ‘protein calculator’ server (http://www.scripps.edu/~cdputnam/protcalc.html).

Additional disordered proteins were selected from IDEAL data set that contained experimentally verified IDPs [51]. The structural disorder of the proteins was varied from 0 to 100%. The proteins with (−1)% disorder were excluded. Structural disorder was further calculated using IUPred algorithm, which is available at http://iupred.enzim.hu [61]. Protein disorderness was estimated by counting the number of residues in disordered regions in a protein as predicted by IUPred and it was divided by the length of the protein sequence followed by multiplication with 100.

Calculating LCR and AR

Protein sequences obtained from DisProt and IDEAL were used to calculate both the LCR and AR. The content of LCR of an individual protein was predicted by SEG method as implemented in SMART (simple modular architecture research tool) [40], [62], a web based server available at http://www.bork.embl-heidelberg.de/Modules/sinput.shtml. Default SEG parameters were used for finding the LCR. The SEG method detects LCRs based on the measurement of information content present in the complexity state vector [40]. The ratio of total number of aa residues in all the LCRs of a protein to the protein sequence length was used to calculate the content of low-complexity region in a particular protein. Amyloidogenic region of the proteins was identified by a web based computational tool Waltz [56], http://waltz.switchlab.org. The % content of residues in AR in a protein was measured by taking a ratio of sequences in all the ARs and the sequence length of the protein.

Prediction of Secondary Structure

APSSP2 was used for the secondary structure prediction of each protein from their aa sequence [59]. The algorithm uses a sequence of amino acids as a query input and predicts the corresponding secondary structure with certain confidence level. Percentages of residues those prefer to be in α-helix, β-strand and coiled conformation were calculated by taking a ratio of total residues in a particular conformation to the sequence length of the proteins. Structural preferences of the residues in ARs and LCRs were obtained by selecting the respective sequence regions in the predicted structure of the protein. Percentage of AR/LCR sequence with a preference for a particular conformation was measured against the total number of AR/LCR sequence in the protein.

Statistical Analysis

All the statistical analysis was performed in Wolfram Mathematica 8. Mean, standard error of mean (SEM), standard deviation (SD) were calculated for AR/LCR length and content. Stable distribution function (Text S1) with index of stability α, skewness parameter β, location parameter μ, and scale parameter σ was fitted to the data to show distribution pattern of AR/LCR length and the AR/LCR content in a protein. Bivariate probability distribution such as smoothed kernel density distribution was used to show the distribution of AR/LCR content with the protein length. To find the correlation between the AR/LCR content and protein sequence length negative hyperbolic equations were fitted to the data.

Results

Content of AR and LCR in Different Classes of IDPs

The DisProt database analysis revealed 221 human proteins and 432 nonhuman (other than human) proteins with different degree of disorderness. Table 1, Tables S1 and S2 list some of these proteins with their physicochemical properties. Additional 186 unstructured human proteins and 25 nonhuman proteins were obtained from IDEAL database (Tables S3 and S4). Tables S1, S2, S3, and S4 show the protein name, database ID and the % of protein disorder measured by IUPred. The tables also show the content (%) of AR and LCR in a particular group of proteins. Last two columns in the tables display the number of ARs found within 15 residues from the C- and N- terminal of the protein sequence and these are marked as ‘C’ and ‘N’ column, respectively. The DisProt database provides the content of structural disorder, however, the disorderness of all the proteins present in IDEAL and DisProt databases was calculated using IUPred server. The proteins from both the databases were arranged in a descending order of disorderness. The content (%) of AR sequences decreased with increasing order of structural disorder. However, a less number of LCR sequence was present in proteins with high content of structural elements.

Table 1. Some of the intrinsically disordered human proteins from DisProt database.

Sl No. DisProt ID Protein Localization/source Function/role PI Sequence length aa# (−,+,0)
1 DP00004_C002 Antibacterial protein LL-37 Secreted Antibacterial activity 10.61 37 5,11,16
2 DP00016 Cyclin-dependent kinase inhibitor 1 Cytoplasm, Nucleus Role cyclin-dependent kinase activity 8.69 164 23, 26, 81
3 DP00017 Cyclin-dependent kinase inhibitor 1C Negative regulator of cell proliferation 5.39 316 31, 27, 202
4 DP00028 Eukaryotic translation initiation factor 4E-binding protein 1 Cytosol Regulates eIF4E activity 5.32 118 14,12, 56
5 DP00039 Non-histone chromosomal protein HMG-17 Cytoplasm, Nucleus Binds to nucleosomal DNA 10.00 89 14, 26, 40
6 DP00040 High mobility group protein HMG-I/HMG-Y Chromosome, Nucleus Processing of mRNA transcripts 10.31 107 15, 27, 36
7 DP00069 Vesicle-associated membrane protein 2 Synaptic vesicles Membrane transport 7.84 116 12,13, 66
8 DP00070 α-synuclein Membrane-bound in dopaminergic neurons Dopamine release and transport 4.67 140 24,15, 73
9 DP000126 Tau [Isoform Tau-F] Axons Microtubule assembly and stability 8.24 441 56, 58, 200
10 DP00174 Stathmin Cytoplasm Regulation of the microtubule (MT) 5.76 149 36, 32, 52
11 DP00199 β-casein Secreted Modulate surface properties of the casein micelles 5.52 226 20,15, 131
12 DP00214 Osteopontin Secreted cell-matrix interaction 4.37 314 75, 29, 103
13 DP00219 Protein phosphatase 1 regulatory subunit 11 Widely expressed Inhibitor of protein phosphatase 1 6.52 126 20,19, 51
14 DP00287 Tumor suppressor [Isoform 1] Cytoplasm Involved in the ubiquitination 4.70 213 41, 23, 114
15 DP00332 Bone sialoprotein 2 Secreted Cell attachment 4.12 317 76, 23, 103
16 DP00357 Thymosin β-4 Cytoplasm Organization of the cytoskeleton 5.02 44 11, 9, 13
17 DP00372 Uncharacterized protein C8orf4 Apoptosis 10.14 106 13, 24, 42
18 DP00510 Nuclear protein 1 Nucleus Proapoptotic stimuli 9.98 82 10, 15, 34
19 DP00521 Securin Cytoplasm, Nucleus Chromosome stability 6.18 202 27, 26, 105
20 DP00546 Huntingtin-interacting protein K [Isoform 1] 5.35 175 34, 29, 81
21 DP00555 β-synuclein Cytoplasm Regulator of SNCA aggregation process 4.41 134 28, 13, 68
22 DP00592 Purkinje cell protein 4 Cytoplasm, Nucleus Nervous system development 6.21 62 11,11, 23
23 DP00617 26S proteasome complex subunit DSS1 Proteolysis 3.81 70 27, 5, 26
24 DP00630 γ-synuclin Cytoplasm Neurofilament network integrity 4.89 127 23, 17, 56
25 Aβ42 APP(Amyloid precursor protein) Cytoplasm Alzheimer disease 5.31 42 6, 3, 25
#

: −, + and 0 represent number of negative (−), positive(+) and neutral amino acids in the protein sequence, respectively.

: from UniProt database and reference therein.

Their localization, function, PI, sequence length and amino acid compositions are listed.

Based on the calculated disorderness, the proteins in each type (human/nonhuman) of proteins were grouped into three categories as suggested in previous report [63]. Proteins with 71–100% structural disorder were grouped as largely disordered proteins (LDPs). Moderately disordered proteins (MDPs) possessed 31–70% sequences in disorder region(s) and the remaining proteins with less than 30% sequences the disorder segment were grouped as partially disordered proteins (PDPs). Sequence details of the AR and LCR in this group of proteins are shown in Table 2. Figure 1 displays the graphical view of the analysis. The number of LDPs was less compared to MDPs and PDPs. Percentage content of amyloidgenic proteins (proteins that contained at least one AR) was also found to be less in LDP group. To gain confidence about this analysis, a t-test was performed based on sequence content (%) in an individual protein of each group (LDP, MDP and PDP). Confidence level was gained from the respective p-values as given in Table S5.

Table 2. Content of AR and LCR sequences in different class of disordered proteins.

Database/Type Class Total number of proteins Amyloidogenic proteins (count) Amyloidogenic proteins (%) AR (count) AR (%) LCR (count) LCR % Overlap regions (count)
DisProt/Human LDP 56 39 69.64 102 3.35 269 21.49 15
MDP 58 53 91.38 248 6.45 223 13.52 11
PDP 107 99 92.52 544 9.35 146 5.51 27
Total 221 191 84.51 894 7.22 638 13.49 53
DisProt/Nonhuman LDP 124 70 56.45 556 3.47 542 27.08 22
MDP 101 82 81.19 325 6.51 286 16.52 17
PDP 207 188 90.82 1008 9.89 243 8.56 35
Total 432 340 78.70 1889 7.26 1071 15.74 74
IDEAL/Human LDP 45 39 86.67 176 3.18 325 16.86 9
MDP 65 61 93.85 311 6.16 248 11.56 20
PDP 76 75 98.68 384 7.78 137 5.56 7
Total 186 175 93.07 871 6.10 710 10.39 36
IDEAL/Nonhuman LDP 8 8 100.00 19 3.40 27 12.00 3
MDP 7 7 100.00 33 7.75 24 19.84 0
PDP 10 9 90.00 60 9.09 15 4.26 2
Total 25 24 96.00 112 6.89 66 11.10 5

LDP, 71–100% disordered protein; MDP, 31–70% disordered protein; PDP, <30% disordered protein.

Figure 1. Content of AR and LCR sequences in different classes of disordered proteins.

Figure 1

(A), DisProt human; (B), IDEAL human; (C), DisProt nonhuman and (D), IDEAL nonhuman. White bar signifying the LCR region, gray bar signifying the AR region and black bar signifying the overlapped region of AR and LCR. (E and F), Percentage of AR and percentage of LCR sequences in different group of disordered proteins, respectively. Bottom-axis in all the plots represents the three groups of disordered proteins with different degree of disorderness, PDP (0–30% disorder), MDP (31–70% disorder) and LDP (71–100% disorder). In (E) and (F), asterisks indicate the statistically significant difference from that of other groups (see Table S5).

Table 2 and Tables S1, S2, S3, and S4 show that some of the proteins in each group contained no AR. For instance, among 221 human proteins in DisProt database, 191 (∼86%) proteins were amyloidogenic and each contained at least one AR. 30 human proteins contained no ARs. The number of amyloidogenic proteins was maximum (93%) for PDPs. However, the value decreased to 70% for the LDPs. A similar trend was observed with nonhuman proteins as presented in Table 2 and Table S2. Analysis of protein sequence from IDEAL database also revealed a similar trend in the content of amyloidogenic protein in different group of proteins (Table 2 and Table S3). Percentage of sequences in low complexity region (LCR) in each and individual protein in DisProt and IDEAL databases are also given in Tables S1, S2, S3, and S4. A group wise distribution of the LCRs is presented in Figure 1 and Table 2. The content of LCR sequence (%) was maximum in LDPs and a little more than 20% of the sequence was found in LCR regions in human proteins found in DisProt. The content of LCR sequences was found to increase with the decrease of structural disorder. Nonhuman DisProt proteins contained slightly higher percentage (16%) of LCR sequences than the proteins in human category. The LCR sequence content in proteins of IDEAL database was less than the DisProt proteins. The content of LCR was least in PDPs. P-values from the t-test of some of the above comparison are given in Table S5.

The sequence length of the AR/LCR and their content varied from protein to protein. Table 3 and Table S6 provide the sequence detail of the ARs, LCRs and the overlap regions between the two regions (AR/LCR). The table provides information regarding AR/LCR length and sequence position of the regions and the percentage of AR/LCR sequences in an individual protein. Individual AR lengths varied from 5 to 34 residues. The content of AR sequences was between 0 to 44% (Tables S1, S2, S3, and S4). For example, the shortest protein, 37 residues long antibacterial LL-37 (DP0004_C002) contained no AR, tau with 441 amino acids enriched with 1.3% AR residues. DP00069 with sequence length of 116 was very rich in AR sequences (14%).

Table 3. LCRs, ARs (*) and overlap regions (†) in some of the human disordered proteins from DisProt data.

DisProt ID LCR/AR Protein length AR (%) LCR (%)
DP00016 GPRRGRDELG GGRRPG (81–96) 164 0 10
DP00017 RLLLAPRPVA VAVAVSPPLE PAAES (101–125) 316 0 43
PSVPVPAPAS TPPPVPVLAP APAPAPAPVA APVAAPVAVA VLAPAPAPAP APAPAPAPVA APAPAPAPAP APAPAPAPAP DAAP (137–220)
AAGTAAASAN GAA (251–263)
VPAPCPSPSA APGVGSV (291–307)
DP00039 KRKAEGDAKG DKAKVKDE (2–19) 89 0 62
AKPAPPKPEP KPKKAPAKKG EKVPKGKKGK ADAGKEG (29–65)
DP00040 SESSSKSS (2–9) 107 0 66
KRGRGRPRKQ PP (23–34)
PKRPRGRPKG SKNKG (54–68)
KTRKTTTTPG RKPRGRPKKL EKEEEEGISQ ESSEEE (71–106)
DP00069 ATAATAPPAA PAGEGGPPAP PP (3–24) 116 14 33
IILGVICAII LIIIIV (97–112)
VICAIILIII IVYFSS (101–116)*
VICAIILIII IV (101–112)†
DP00070 KAKEGVVAAA EKTK (10–23) 140 4 21
EGVLYV (35–40)*
VTNVGGAVVT GVTAVA (63–78)
DP00126 SKSKDGTGSD DKKAKGADGK TKIAT (129–153) 441 1 17
PAKTPPAPKT PPSSGEPPKS GDRSGYSSPG SPGTPGSRSR
TPSLPTPPTR EP (172–223)
KVQIIN (274–279)*
DP00174 AFELI (19–23)* 149 3 0
DP00199 VLILACLVAL A (3–15) 226 0 38
ETIESLSSSE ESITE (17–31)
HEDQQQGEDE HQD (41–53)
LPLAQPAVVL PVPQP (82–96)
LHLPLPLLQP LMQQVPQPIP Q (139–159)
LLLNQELLLN (196–205)
DP00214 SHDHMDDMDD EDDDDHVDSQ DSIDSNDSDD VDDTDDSHQS 314 0 20
DESHHSDESD E (81–131)
EFHSHEFHSH E (272–282)
DP00219 ETVTETTVTV TTE (10–22) 126 0 37
ESSTESDEEE EE (72–83)
PTPTTPPQPP DPSQPPPGPM Q (105–125)
DP00287 EAEVGAEEAG VEEYGPEEDG GEESGAEESG PEESGPEELG 213 8 23
AEEEMEAG (10–57)
SQVIF (72–76)*
IFANITLPVY TL (147–158)*
DP00332 GSSDSSEENG DDSSEEEEEE EETSNEGEN NEESNEDEDS EAENTT (62–106) 317 3 41
KEKESDEEEE EEEEGNENEE SEAEVDENE (145–173)
TGANAEGTTE TGGQGKGTSK TTTSPNGG (207–234)
GKTTTVEYEG EYEYTG (252–267)
GQGYDGYDGQ NYY (302–314)
GQNYYHHQ (310–317)*
GQNYY (310–314)†
DP00372 HQAIIM (7–12)* 106 17 0
AVGNIF (35–40)*
IIFAID (66–71)*
DP00510 EDEDSSLDES DLYSL (18–32) 82 0 31
GGGGRKGRTK RE (38–48)
DP00521 ATLIYV (2–7)* 202 3 5
PPSPVKMPSP P (163–173)
DP00546 GAERRCGPGP APPPPRAEA (16–34) 175 5 21
RRSREQKAKQ EREKELAK (116–133)
VEAL IALTN (167–175)*
DP00555 EGVLYV (35–40)* 134 8 28
GAGNIA (73–78)*
EEVAQEAAEE PLIEPLMEPE GESYEDPPQE EYQEYEPE (96–133)
DP00592 AAVAIQ (42–47)* 62 10 0
DP00617 LLEEDDEFEE F (12–22) 70 0 36
VWEDNWDDDN VEDD (38–51)
DP00630 AVSEAVVSSV NTVATKTV (65–82) 127 0 30
QQEGEASKEK EEVAEEAQSG (106–125)
Aβ42 KLVFFA (16–21)* 42 29 0
GGVVIA (37–42)*

Sequence positions are given in the parentheses. Single letter code is used to represent individual aa residues.

In contrast to ARs, most of the LCRs were 8–40 residues long. The shortest LCR was 8 residues long. One such region was detected in DP00040. The largest LCR of 84 residues long was detected in DP00017. LCRs in tau (DP00126), for instance, occupied 17% of its total sequences. More than 35% residues in β-casein (DP00199) and regulatory subunit 1 (DP00219) were in LCRs.

Statistical Analysis

Statistical analysis was carried out to reveal the average of AR/LCR content (%) and the length of the two regions (AR/LCR) in human proteins. To obtain the statistical parameters, AR/LCR content in all the human proteins from DisProt and IDEAL databases (Tables S1 and S2) was combined. The total number of proteins examined was 407 and the combined number of AR and LCR were 1765 and 1348, respectively, (Table 2).

A stable distribution function (see Materials and Methods and Text S1) was applied to the experimental data (detected ARs and LCRs). Figure 2 shows the frequency histogram and the fitted distribution function for both the LCR and AR. Table 4 reports the statistical parameter values estimated from the fit to ARs/LCRs. It was found that the statistical population (% of AR/LCR sequences) was characterized by a positive (and much larger than zero) value of the skewness coefficient. The mean value was ∼8% of sequences for the AR. A similar distribution fit was made to the available lengths of the ARs/LCRs as shown in Figure 3 and the mean value was about 8 residues for the AR and 34 residues for the LCR.

Figure 2. Probability distribution of LCR and AR lengths and percentages.

Figure 2

Distribution of LCR lengths (A) and percentage of LCR (B) in LCR containing disordered proteins. C and D, respectively; represent probability distribution of AR lengths and AR content (%) of IDPs. Fitted statistical parameters are given in Table 4. Histograms of data are shown with a suitable bin size.

Table 4. Statistical analysis on AR/LCR length/content.

Stable distribution parameters AR length distribution AR percentage distribution LCR length distribution LCR percentage distribution
Index of stability, α 1.02 1.34 0.92 1.08
Skewness parameter, β 0.99 0.99 0.99 0.99
Location parameter, μ 6.55 9.73 14.99 9.73
Scale parameter, σ 0.94 2.24′ 4.67 2.24

Stable distribution function fitting parameters.

Figure 3. Smoothed kernel density estimation for the LCR and AR content in a protein.

Figure 3

Left and right panel, respectively, represents the density for LCR and AR. The plots have been shown in two different clipping planes. Bottom figures show the smoothed 3D histogram for the AR and LCR.

Figure 3 shows the smoothed kernel density estimation for the LCR/AR content in a protein (left and right panel, respectively). The plots have been shown in two different clipping planes. Bottom figure shows the smoothed 3D histogram. The smoothed kernel density estimation plot shows a distinct peak suggesting ∼8% AR content in a ∼400 aa long protein and indicated that the detected proteins in the two databases populated at ∼400 aa long and largely contributed to the estimate of average content of the AR and LCR. No correlation could be observed between the AR/LCR content and protein length (Figure 4). Although at deeper clipping plane it suggested a negative hyperbolic fit i.e. with the increase in protein length there is decrease in the AR/LCR content. However, no significant fit could be obtained to validate this assumption.

Figure 4. Correlations between content of LCR and AR sequence with the protein length.

Figure 4

(A) Correlations between content of LCR sequence with the protein length. No significant correlation could be obtained for the LCR content in a protein sequence. The figure shows a negative hyperbolic fit (y = 9.44056+1926.61/x; R2, 0.113058) with standard deviation bands (at 1σ, 2σ, and 3σ). (B) Correlations between content of AR sequence with the protein length. No significant correlation could be obtained for the AR content in a protein sequence. The figure shows a negative hyperbolic fit (y = 6.05937+651.62/x; R2, 0.112173) with standard deviation bands (at 1σ, 2σ, and 3σ).

Sequence Aspects of AR and LCR

One interesting observation was that a major number of proteins contained both the AR and LCR, however, the two regions rarely overlapped with each other (Figure 1, Tables S1, S2, S3, and S4, Table 3 and Table 5). For instance, DisProt human proteins contained 894 ARs and 638 LCRs, however, only 53 occurrences of sequence overlapping between the two regions were observed and in most of the cases the overlap was partial (Table 5). A LCR with residues 97–112 in DP00069 overlapped with C-terminal AR of residues 101–116, and the overlapping region contain 12 residues. Whereas in DP00332, LCR with residues from 302–314 overlapped with an AR (310–317). Only four residues were found in the overlapping region. Similarly four ARs from DP00119, DP00551, DP00643_A002 and DP00683 partially overlapped with the LCRs. In other group of proteins also a similar result was obtained. Among 1889 AR regions in DisProt nonhuman proteins, only 74 ARs overlapped with the LCRs. In an average, ∼3% of the AR sequences overlapped with the LCR sequences. These observations clearly indicated that the residues in AR were very complex and rarely overlapped with the LCR.

Table 5. Overlapping regions in DisProt human proteins.

Disprot ID LCR/AR overlap region
DP00069 LCR IILGVICAIILIIIIV---- (97–112)
AR ----VICAIILIIIIVYFSS (101–116)
DP00332 LCR GQGYDGYDGQNYY--- (302–314)
AR --------GQNYYHHQ (310–317)
DP00119 LCR LLILLSVALLALSSAESSSEDVSQEESL---- (2–29)
AR --------------------------SLFLIS (28–33)
DP00551 LCR ALLLLLFLHLAFL (10–22)
AR --LLLLFLHLAFL (12–22)
DP00643_A002 LCR VILRLLRYIVRLVWR-- (122–136)
AR ----LLRYIVRLVWRMH (126–138)
DP00683 LCR LVSVYNSYPYYPYLY- (210–224)
AR LVSVYNSYPYYPYLYC (210–225)
DP00012 LCR -----FNSSAFFFSGFFVVFLSV----------- (305–322)
AR AYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIIL (300–333)
LCR IQLLLIVIGAIAVVAVLQ (995–1012)
AR -QLLLIVIGAIA------ (996–1006)
LCR -IFVIFFIAVTFISI-- (1106–1119)
AR MIFVIFFIAVTFISILT (1105–1121)
DP00074 LCR AAYEFNAAAAANA (58–70)
AR AAYEFN------- (58–63)
LCR LTLQQQHQRLAQLLLIL- (495–511)
AR -----------QLLLILS (506–512)
DP00099 LCR ---TIITPPTPIIP (336–346)
AR AGWTIIT------- (333–339)
DP00162 LCR TTGVVTVIVILIAIAALGALILG----- (9–31)
AR -------IVILIAIAALGALILGCWCYL (16–36)
DP00191 LCR LLLLLFL-- (8–14)
AR -LLLLFLKS (9–16)
DP00231 LCR ------QTPQGQQGLLQAQNLLTQLPQQ (210–231)
AR AQFIISQ--------------------- (204–210)
DP00272 LCR --------LALADALATSTL (112–123)
AR ATNIYIFNLA---------- (104–113)
DP00282 LCR KNNWNIEDNNIKN (1132–1144)
AR -NNWNIE------ (1133–1138)
DP00306 LCR ----ITILIIALIAL------ (51–61)
AR NVVFITILIIALIALSVGQYN (47–67)
DP00307 LCR LEQILEYELLLIQQL------ (140–154)
AR -------ELLLIQQLNFHLIV (147–160)
DP00311 LCR AVAGLVLVALLAILV---- (232–246)
AR --------ALLAILVENWH (240–250)
DP00314 LCR PKLPDDTTFPLPPPRPK----- (149–165)
AR ----------------KNVIFE (165–170)
DP00317 LCR TEKRKKRSTKKE---------- (301–312)
AR -----------EVFNILQAAYV (312–322)
DP00324 LCR GGNFGGRSSGPYGGGG--- (329–344)
AR --------------GGQYF (343–347)
DP00338 LCR MILFLIMLVLVLF--- (20–32)
AR -ILFLIMLVLVLFGYG (21–35)
DP00339 LCR MILFLIMLVLVLF--- (20–32)
AR -ILFLIMLVLVLFGYG (21–35)
LCR GDFYYLGGFFGG (261–272)
AR GDFYYLGGFFG- (261–271)
DP00356 LCR NNQYFNHHPYPHNHYMP (120–136)
AR NNQYFN----------- (120–125)
DP00381 LCR -----NNTQTTTHLQPLHHP (819–833)
AR ELNNINNTQ----------- (814–822)
DP00406 LCR LQALYALQALVVTL- (1522–1535)
AR LQALYALQALVVTLE (1522–1536)
DP00428 LCR -------LELCRRRSLLEL (130–141)
AR NDFVFVVLEL--------- (123–132)
DP00448 LCR LVVKTALKLLLVFV--- (217–230)
AR --------LLLVFVEYS (225–233)
DP00464 LCR KKLKEKKDELD--------- (45–55)
AR ---------LDSLITAITTN (54–64)
DP00466 LCR SPPVILLISFLIFLIV- (237–252)
AR ---VILLISFLIFLIVG (240–253)
DP00467 LCR AKPNATTANGNTALAIA (785–801)
AR -----------TALAIA (796–801)
DP00503 LCR ---------LLIILFIIVPIFLLL (167–181)
AR KDGIIMIQTLLIILFIIVPIFLL- (158–180)
DP00508 LCR LAVLILAIILL------ (7–17)
AR LAVLILAIILLQGTLAQ (7–23)
DP00519 LCR -----SSGAKSPSKSGA (1355–1366)
AR KAVEFSS---------- (1350–1356)
LCR LEELEKERSLLLADLDKEEKEKD----------- (134–156)
AR ---------------------KDWYYAQLQNLTK (155–167)
DP00520 LCR KSPKGSGKPPGVPASSKSGK------ (332–351)
AR -------------------KAFSYYL (351–357)
DP00553 LCR ASLLFLNVLAFAAL- (716–729)
AR ASLLFLNVLAFAALY (716–730)
DP00574 LCR GPGRLEREAAAAAATTPAPTAGAL--- (52–75)
AR --------------------AGALYSG (72–78)
LCR -----SGSEGDSESGEEEELGAE (77–94)
AR AGALYSG---------------- (72–78)
DP00616 LCR LVFLVLLFLGALGLCLA (3–19)
AR ---LVLLFLGA------ (6–13)
DP00628 LCR LRELSELSLLSL-- (235–246)
AR --------LLSLYG (243–248)
DP00632 LCR YSTYSQAAAQQGYSAYTAQ (6–24)
AR -----------GYSAYTA- (17–23)
LCR ---SYTQAQTTATYGQTAYATSYGQPPTGYTTPTAPQA (51–85)
AR TDVSYTQAQTTATYGQTAYATSYG-------------- (48–71)
LCR QPVTAPPSYPPTSYSSTQPTSYDQSSYSQQNTYG…QSS (182–266)
AR ----------------------------QQNTYG------ (210–215)
DP00633 LCR -LQAYQQRLLQQQ (2257–2268)
AR SLQAYQ------- (2256–2261)
DP00641 LCR AALLWLLLIAAA-- (5–16)
AR AALLWLLLIAAAFS (5–18)
DP00666 LCR IILLLLVLLIL-- (1130–1140)
AR -----LVLLILCF (1135–1142)
DP00670 LCR AVAAAAIFVIIIF- (314–326)
AR --AAAAIFVIIIFY (316–327)
DP00706 LCR GKGDSSGFSSYSGSSSSGSSISSARSSGGGSSG…AGS (58–105)
AR ------GFSSYS--------------------------- (64–69)
LCR GYSQVSYSSGSGSSLQGASGSSQLGSSSSHSGNSGS…GSA (111–175)
AR --SQVSYSS--------------------------------- (113–119)

Length and sequence positions are given in the parentheses. Single letter codes are used to represent individual aa residues. Overlapping regions are aligned. Only the proteins with AR/LCR overlapping regions are shown.

We also calculated average content of different types of amino acid residues in both the AR and LCR. Figure 5 displays the average content of different types of residues present in the AR, LCR and total proteins. A major fraction of the AR residues was hydrophobic and Leu was the most abundant (12.6%) residue. Other major residues in the region were Ile (11.2%), Phe (8.8%), Tyr (8.6%), Val (8.1%), Ala (7.3%). The AR regions were depleted in Pro, Lys, His and others. A major number of residues in the LCR was hydrophilic in nature and the regions were enriched with Ser (13.1%), Pro (12.1%), Gly (9.8%) and Ala (9.2%).

Figure 5. Content of different types of aa residues present in the LCR, AR and total proteins.

Figure 5

The panel compares the percentage of individual aa residues in the LCR (Series 1, blue), AR (Series 2, red), and total protein (Series 3, green). X-axis started with the most abundant residues in the AR. The amino acid residues are presented with a single letter code along the bottom axis.

The structural propensities of residues in the ARs were measured using the APSSP2 algorithm (see Materials and Methods). The analysis showed that the conformational preference of the AR residues was not confined to any particular structure, rather in average a mixed structural preference of the AR residues was observed in all three groups of proteins. Figure 6 displays the overall structural heterogeneity of the AR sequences present in human (DisProt) proteins. The average number of sequence that preferred α-helical conformation was ∼38%. Preferences for β-sheet/strand and coil conformations were ∼31% and ∼32%, respectively. This result indicated that all of the sequences in the ARs did not favour β-conformation. When compared with total protein sequence present in the same group of proteins, about 56% residues preferred coil conformation and ∼30% residues showed structural propensity towards α-helical conformation. Remaining 14% favoured β-sheet/strand conformations. Number of residues that preferred β-sheet component increased substantially in the ARs, however, large fraction of the AR residues (38%) favoured α-helical conformation.

Figure 6. Comparison of the conformational preferences of residues in the ARs with that of total protein.

Figure 6

A 3D plot shows the percentage of residues with conformational preference for α-helix (green), β- strand/sheet (red) and coil (blue) for total proteins and their ARs as represented in X-axis. Lower panel shows the 2D plot of the above data along with the error limits.

Discussion

It is known from previous investigations that AR acts as a key for several protein aggregations and amyloid fibril formation. In this report we detected ARs by using Waltz algorithm and analyzed computationally the sequence complexity, conformational preference and the distribution of ARs in disordered human proteins present in Disprot and IDEAL databases. There are several methods to detect ARs [56], [64][66]. Some important algorithms and software to predict aggregation aspects of proteins are Tango [55], Waltz [56], PASTA [67][70], Aggrescan [71], SALSA [72], Zyggregator [73], AmylPred [64], FoldAmyloid [74]. The ability of the protein sequences to form β-strands/sheets is a predominant feature in most of these algorithms. PASTA was developed based on hidden β-propensity of the protein sequences [67][70]. Aggrescan software was based on an aggregation propensity scale for the 20 natural amino acids [71]. This method stressed that short and specific sequence stretches were responsible for protein aggregation. Based on average packing density of the aa residues, FoldAmyloid identified a sequence pattern that could promote amyloid fibril formation [34]. Waltz methodology was used in this investigation because many of its selected regions were experimentally verified and the method was better capable to differentiate amyloid fiber formation and amorphous aggregates [56].

The investigation revealed that more than ∼80% disordered human proteins (DisProt and IDEAL databases) possessed at least one AR, indicating that a significant number of disordered proteins were amyloidogenic. Waltz detected ARs from a large number of proteins in DisProt and IDEAL databases. The large number of data set helped to derive, along with discrete analysis (Table 6), statistical average of AR and LCR sequence percentage and the average of AR and LCR sequence length. Discrete analysis result of all groups of proteins is given in Table 2 and Table 6. The average values did not differ much with statistical analysis result (Table 4). However, the statistical values may be more acceptable to represent the average properties and composition of the LCRs and ARs.

Table 6. Discrete analysis.

Protein type AR (%) LCR (%)
Range Mean Median Range Mean Median
DisProt human 0.43–31.50 8.36 6.98 1.41–91.94 15.86 10.21
DisProt nonhuman 1.20–44.00 9.27 7.50 1.30–96.80 16.80 12.20
IDEAL human 0.69–22.37 6.56 5.93 1.09–70.80 13.74 10.93
IDEAL nonhuman 1.08–17.53 7.03 6.69 1.67–70.67 13.15 8.14

Range, Mean, Median and Mode of AR and LCR sequence percentage in different group of proteins.

Percentage of amyloidogenic proteins was higher in the PDP groups. Thus the content of AR sequences was more in proteins with less structural disorder or in structured proteins. A similar observation was also made by Linding et al. [75]. These proteins contained less number of LCRs which were composed of less number of hydrophobic amino acids. LCR thus may have a significant role in protein aggregation process and amyloid formation. AR may be exposed to start the aggregation process and LCR regions could have certain role in the process. However, a large number of LCR along with a high content of polar amino acids and attenuated hydrophobicity may not allow the protein to misfold/fold further to gain β-sheet rich amyloid aggregate, in largely disordered proteins [3]. Therefore, the content of AR and LCR and the unique balance between the two regions are very crucial for protein stability (for disordered proteins) and amyloid formation. A proper solution condition may be needed based on the content of AR/LCR to unfold the region of structured proteins partially or fully to trigger amyloid fiber formation [76]. Nature may have designed the disordered proteins with a unique balance of AR and LCR sequences to provide stability and the ability to perform multifunction. However, an external disturbance or change in internal cellular condition may break this unique balance and could enhance protein aggregation and amyloid formation.

Most of the detected ARs in amyloidogenic proteins were six to eight residues long. We detected six residues long (residues 35–40) AR in α-synuclein. It was significantly shorter than the aggregation prone segment obtained by Der-Sarkissian et al. Zhang et al. showed four additional segments that might be involved in α-synuclein aggregation [72]. However, the used methods did not define adequately the characteristics of nucleation site of amyloid formation. Waltz allowed identification and better distinction between amyloid sequences from the protein segments that promote β-sheet rich amorphous aggregates, and that could be a possible reason of less number of AR regions found in this investigation.

Statistical analysis results and discreet analysis (Tables S1, S2, S3, and S4, Table 6) established that the content of AR sequences was not always proportional to the protein sequence length. It showed a negative hyperbolic correlation among the protein sequence length and the percentage of AR/LCR sequence (Figure 4). The reason of this was not known. Chiti et al. observed less aggregation propensity of proteins those were longer with respect to short proteins [77]. The longer proteins thus may have evolved with attenuation (low content) of ARs to reduce unwanted aggregation and fibril formation. It would be interesting, however, to test whether increasing number of ARs could enhance the aggregation kinetics or the quality of fibril formation in longer proteins.

In this regard, it was also important to know the conformational preferences of AR residues. We observed that aa residues in the ARs showed propensity towards α-helix, β-sheet/strand and coil conformations and all the residues were not very hydrophobic. Waltz, used in this investigation, did not fully rely on β-sheet structural propensity of the residues but was built on PSSM and on consideration of other physicochemical properties of the protein sequences. It allows some tolerance towards charged and polar residues with different hidden structural propensity. Proteins with diverse structural domains (β-sheet, α-helix, or random coil) including globular proteins were found to produce aggregates with fibrillar structure under certain solution condition [23], however, a crucial structural rearrangement often occurred during conversion of these proteins into amyloid fiber [78]. Thus slightly polar amino acids or the presence of LCR may play important role in structural reorganization.

Aggregation propensity and overall protein aggregation may also depend on the location of AR in the protein sequence, and how the ARs are surrounded by local excess of polar/charged amino acids or LCRs. Kar et al. recently showed that addition of a polyproline sequence to C-terminal side of polyGlu slowed aggregation of the peptide [48]. However insertion of the same residues to the N-terminal side of polyGlu caused very little effect on overall aggregation of the peptide. N-terminal residues in Huntingtin protein situated adjacent to the polyGlu sequence dramatically altered aggregation property of the peptide. However, position dependent role of LCRs, rich in polar and charged residues, on aggregation propelled by ARs was not known with certainty. According to amyloid stretch hypothesis the AR containing proteins were needed to be locally/partially unfolded to initiate and promote the process of amyloid fiber formation [35]. Thus the presence of LCR in a protein with less disorder may significantly alter the amyloid formation kinetics.

The IDPs play a vital role in molecular recognition process and the interaction has found to lead formation of structured protein complexes. A model of molecular recognition features or elements (MoRFs) has been proposed to define this interaction and the reorganization processes [79][82]. The MoRF model recognizes, in a disordered protein sequence, a linear region that undergoes a disorder-to-order transition upon binding to its partner. These regions are often referred as MoRFs. The regions could attain α-helices, form β-strands (β-MoRFs), irregular structures (ι-MoRFs), and a combination of all these structural elements upon binding to its partner. However, our analysis largely directed to find the amyloid forming region and the region of protein sequences that are sequentially less complex. Both the AR and LCR could be part of MoRFs and may be involved in molecular reorganization process. However, further analysis may be needed to address this issue.

One of the significant observations was that the AR sequences were highly complex. Our analysis with IDPs showed that ∼20% sequence was in the LCR and the value was close to the overall predicted value for SWISS-PROT database [41]. However most (greater than 97%, Table 2) of the AR sequences were not within the LCRs. It indicated complexity pattern of the AR sequences and confirmed the presence of less number of biased aa residues in the ARs. Some LCRs with one or more aa residues form stretches of a single amino acid, produce homopolymeric structure [41], [49], [40], [83] and became amyloidogenic [84]. However, we could detect in IDPs no such LCR which were polymeric in nature and amyloidogenic. Many prion proteins, e.g mammalian PrP, the yeast prions, Ure2p and Sup35 contain disordered stretches that also form beta sheet rich aggregates. These aggregate prone domains are also found to contain segments with low sequence complexity and often are enriched with Glu/Asp [85][88]. Thus prion proteins also contained both the ARs and LCRs. A test was performed with prion protein (P04156) and Huntingtin (P42858), however waltz methods could detect the palindromic region (residue 112–119) in P04156 and polyQ region in Huntingtin (P42858) only when ‘custom’ is used as the threshold in the analysis [56]. In our analysis, ‘best overall performance’ was used as the threshold and it missed the detection of above two amyloidogenic regions. We also analysed the content of ARs and LCRs in a group of proteins which were amyloidogenic and the amyloidogencity of the proteins were experimentally proven [56]. The list of the proteins and the analysis results are shown in Table 7. It includes protein like insulin, prion protein (P04156) and yeast protein Sup 35 (P05453). The observation was that the sequence overlapping of the AR and LCR were also very less (Table 7). This indicated that the ARs are compositionally highly complex. As such the sequence complexity and structural heterogeneity of the AR sequences was a vital observation. Also a few % of residues that overlapped with the LCR showed mixed structural propensity. The C terminal LCR in DP00069 that overlapped with the AR contained seven Ile (not at a stretch) and these residues showed preference for α-helical conformation. The overlapping sequences of AR and LCR, however, in DP00332 showed propensity towards random coil structure. Being a part of an AR both the overlapping regions was expected to induce aggregation in a certain solution condition. However, the LCR component may modulate the aggregation process in different way and the content may be changed depending on the solution condition [89]. Future experiments, starting with these overlapping ARs and LCRs, would enhance our understanding about how the sequence region composed of AR with low complexity sequences would modulate the protein aggregation process that lead to eventual formation of amyloid fiber.

Table 7. Content of ARs and LCRs in a group of known amyloidogenic proteins.

Name UniProt ID Sequence length LCR LCR (%) AR AR (%) Overlapping sequences
Insulin P01308 110 2–24 20.91 36–42 17.30
99–110
Apolipoprotein A1 P02647 267 8–15 3.00
Cold shock protein cspB P32081 67 14–20 8.20
26–34
47–52
Acylphosphatase2 P14621 99
Immunoglobulin G-binding protein G P06654 448 69–114 24.55
241–253
379–413
427–442
Alpha- synuclein P37840-1 140 10–23 35–40
63–78
PI3-kinase alpha P27986 724 79–102 7.18 72–78 6.40
303–314 263–269
533–548 290–296
331–336
401–406
483–495
Microtubule-associated protein Tau P10636 441 274–279 1.36
Cystatin-C P01034 146 2–33 21.92 10–20 22.60 10–20
56–61
84–92
124–130
Ig kappa chain V-I region Rei P01607 108 32–37 20.40
45–53
71–77
Lysozyme C P00698 147 52–62 11.60
142–147
Major prion protein PrP P04156 253 50–94 38.74 8–17 19.40 240–252
113–135 171–176
188–201 178–185
237–252 222–227
231–235
240–253
Sup35 P05453 685 5–64 27.88 9–18 20.00 9–18
68–113 31–36 31–36
130–142 45–56 45–56
164–209 69–74 69–74
241–253 102–108 102–108
398–410 260–266
278–285
304–313
426–445
471–476
527–538
566–571
584–596

Proteins were selected from the reference 56.

Conclusion

The current investigation was focused on sequence complexity and content of AR present in proteins which were partially or fully disordered. The study observed a very high sequence complexity of the ARs and the regions not commonly overlapped with the LCRs which were abundant in the protein sequence. The future investigation may examine experimentally whether a unique balance between the content of AR and LCR could provide a suitable stability to a monomeric disordered protein to remain in a solution state. It would be interesting to examine how the spacing of LCR and AR and, swapping of AR positions influence the energetic of amyloid fiber formation. It will enhance our understanding why some proteins favor aggregation in a certain environment and may add more information about the mechanism of amyloid formation which is linked to several pathological human disorders.

Supporting Information

Text S1

Stable distribution function. Details of the statistical distribution function applied to AR/LCR length/content distribution.

(DOCX)

Table S1

DisProt human proteins. Protein name, database IDs and AR/LCR content measured by IUPred are listed. Last two columns in the tables display the number of ARs found within 15 residues from the C- and N- terminal of the protein sequence and these are marked as ‘C’ and ‘N’ column, respectively.

(XLSX)

Table S2

DisProt nonhuman proteins. Protein name, database IDs and AR/LCR content measured by IUPred are listed. Last two columns in the tables display the number of ARs found within 15 residues from the C- and N- terminal of the protein sequence and these are marked as ‘C’ and ‘N’ column, respectively.

(XLSX)

Table S3

IDEAL human proteins. Protein name, database IDs and AR/LCR content measured by IUPred are listed. Last two columns in the tables display the number of ARs found within 15 residues from the C- and N- terminal of the protein sequence and these are marked as ‘C’ and ‘N’ column, respectively.

(XLSX)

Table S4

IDEAL nonhuman proteins. Protein name, database IDs and AR/LCR content measured by IUPred are listed. Last two columns in the tables display the number of ARs found within 15 residues from the C- and N- terminal of the protein sequence and these are marked as ‘C’ and ‘N’ column, respectively.

(XLSX)

Table S5

The t-test results for the comparison of different group of proteins. The p-values were obtained using inbuilt program in Microsoft Office Excel.

(XLSX)

Table S6

AR sequences and their positions in DisProt proteins. UniProt and DisProt IDs and the AR/LCR percentages in respective proteins are given.

(XLSX)

Acknowledgments

We wish to thank the reviewers for their constructive suggestions and comments, which helped to organise and strengthen the presentation of the article.

Funding Statement

This work was supported by grants GENESIS (BSC0121) and miND from the Council of Scientific & Industrial Research (CSIR), India. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1. Tompa P (2003) Intrinsically Unstructured Proteins Evolve by Repeat Expansion. BioEssays 25: 847–855. [DOI] [PubMed] [Google Scholar]
  • 2. Radivojac P, Iakoucheva LM, Oldfield CJ, Obradovic Z, Uversky VN, et al. (2007) Intrinsic Disorder and Functional Proteomics. Biophys J 92: 1439–1456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Dosztányi Z, Mészáros B, Simon I (2010) Bioinformatical Approaches to Characterize Intrinsically Disordered/Unstructured Proteins. Brief Bioinform 11: 225–243. [DOI] [PubMed] [Google Scholar]
  • 4. Sickmeier M, Hamilton JA, LeGall T, Vacic V, Cortese MS, et al. (2007) Disprot: The Database of Disordered Proteins. Nuc Acids Res 35: D786–D793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Bryson K, Cozzetto D, Jones DT (2007) Computer-Assisted Protein Domain Boundary Prediction Using the Dom-Pred Server. Curr Protein Pept Sci 8: 181–188. [DOI] [PubMed] [Google Scholar]
  • 6. Dunker A, Lawson J, Brown C, Williams R, Romero P, et al. (2001) Intrinsically Disordered Protein. J Mol Graph Model 19: 26–59. [DOI] [PubMed] [Google Scholar]
  • 7. Pietrosemoli N, Garcia-Martin JA, Solano R, Pazos F (2013) Genome-Wide Analysis of Protein Disorder in Arabidopsis Thaliana: Implications for Plant Environmental Adaptation. PLOS ONE 8: e55524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Maestro B, Galan B, Alfonso C, Rivas G, Prieto MA, et al. (2013) A New Family of Intrinsically Disordered Proteins: Structural Characterization of the Major Phasin PhaF from Pseudomonas putida KT2440. PLOS ONE 8: e56904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Burra PV, Kalmar L, Tompa P (2010) Reduction in Structural Disorder and Functional Complexity in the Thermal Adaptation of Prokaryotes. PLOS ONE 5: e12069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Orosz F, Ovadi J (2011) Proteins without 3D Structure: Definition, Detection and Beyond. Bioinformatics 27: 1449–1454. [DOI] [PubMed] [Google Scholar]
  • 11. Schweers O, Schoenbrunn-Hanebeck E, Marx A, Mandelkow E (1994) Structural Studies of Tau Protein and Alzheimer Paired Helical Filaments Show No Evidence for Beta-Structure. J Biol Chem 269: 24290–24297. [PubMed] [Google Scholar]
  • 12. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, et al. (2000) α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress. Am J Pathol 157: 401–410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Uversky VN (2002) What Does It Mean to Be Natively Unfolded? Eur J Biochem 269: 2–12. [DOI] [PubMed] [Google Scholar]
  • 14. Ahmad A, Uversky VN, Hong DP, Fink AL (2005) Early Events in the Fibrillation of Monomeric Insulin. J Biol Chem 280: 42669–42675. [DOI] [PubMed] [Google Scholar]
  • 15. Weinreb P, Zhen W, Poon A, Conway K, Lansbury P (1996) NACP, A Protein Implicated in Alzheimer's Disease and Learning, is Natively Unfolded. Biochemistry 35: 13709–13715. [DOI] [PubMed] [Google Scholar]
  • 16. Wright P, Dyson H (1999) Intrinsically Unstructured Proteins: Re-Assessing the Protein Structure-Function Paradigm. J Mol Biol 293: 321–331. [DOI] [PubMed] [Google Scholar]
  • 17. Dunker A, Cortese M, Romero P, Iakoucheva L, Uversky V (2005) Flexible Nets: The Roles of Intrinsic Disorder in Protein Interaction Networks. FEBS J 272: 5129–5148. [DOI] [PubMed] [Google Scholar]
  • 18. Uversky VN (2003) Protein Folding Revisited. A Polypeptide Chain at the Folding-Misfolding-Nonfolding Cross-Roads: Which Way to Go? Cell Mol Life Sci 60: 1852–1871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Dunker K, Obradovic Z (2002) The Protein Trinity: Importance of Intrinsic Disorder for Protein Function. Hum Genome News 12: 13–14. [Google Scholar]
  • 20. Dosztanyi Z, Chen J, Dunker A, Simon I, Tompa P (2006) Disorder and Sequence Repeats in Hub Proteins and Their Implications for Network Evolution. J Proteome Res 5: 2985–2995. [DOI] [PubMed] [Google Scholar]
  • 21. Tompa P (2002) Intrinsically Unstructured Proteins. Trends Biochem Sci 27: 527–533. [DOI] [PubMed] [Google Scholar]
  • 22. Dyson H, Wright P (2002) Coupling of Folding and Binding for Unstructured Proteins. Curr Opin Struct Biol 12: 54–60. [DOI] [PubMed] [Google Scholar]
  • 23. Uversky VN, Fink AL (2004) Conformational Constraints for Amyloid Fibrillation: The Importance of Being Unfolded. Biochim Biophys Acta Proteins Proteomics 1698: 131–153. [DOI] [PubMed] [Google Scholar]
  • 24. Hegyi H, Buday L, Tompa P (2009) Intrinsic Structural Disorder Confers Cellular Viability on Oncogenic Fusion Proteins. PLOS Comput Biol 5: e1000552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Rochet JC, Lansbury PT Jr (2000) Amyloid Fibrillogenesis: Themes and Variations. Curr Opin Struct Biol 10: 60–68. [DOI] [PubMed] [Google Scholar]
  • 26. He B, Wang K, Liu Y, Xue B, Uversky VN, et al. (2009) Predicting Intrinsic Disorder in Proteins: An Overview. Cell Res 19: 929–949. [DOI] [PubMed] [Google Scholar]
  • 27. Kelly JW (1998) The Alternative Conformations of Amyloidogenic Proteins and Their Multi-Step Assembly Pathways. Curr Opin Struct Biol 8: 101–106. [DOI] [PubMed] [Google Scholar]
  • 28. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, et al. (1997) Alpha-Synuclein in Lewy Bodies. Nature 388: 839–840. [DOI] [PubMed] [Google Scholar]
  • 29. Yagi H, Takeuchi H, Ogawa S, Ito N, Sakane I, et al. (2010) Isolation of Short Peptide Fragments From Alpha-Synuclein Fibril Core Identifies a Residue Important for Fibril Nucleation: A Possible Implication for Diagnostic Applications. Biochim Biophys Acta Proteins Proteomics 1804: 2077–2087. [DOI] [PubMed] [Google Scholar]
  • 30. Uversky VN, Eliezer D (2009) Biophysics of Parkinson's Disease: Structure and Aggregation of Alpha-Synuclein. Curr Protein Pept Sci 10: 483–499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Fandrich M, Forge V, Buder K, Kittler M, Dobson C, et al. (2003) Myoglobin Forms Amyloid Fibrils by Association of Unfolded Polypeptide Segments. Proc Natl Acad Sci U S A 100: 15463–15468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Goldschmidt L, Teng PK, Riek R, Eisenberg D (2010) Identifying the Amylome, Proteins Capable of Forming Amyloid-Like Fibrils. Proc Natl Acad Sci U S A 107: 3487–3492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Ivanova M, Sawaya M, Gingery M, Attinger A, Eisenberg D (2004) An Amyloid-Forming Segment of β2-Microglobulin Suggests a Molecular Model for the Fibril. Proc Natl Acad Sci U S A 101: 10584–10589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Lopez de la Paz M, Serrano L (2004) Sequence Determinants of Amyloid Fibril Formation. Proc Natl Acad Sci U S A 101: 87–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Esteras-Chopo A, Serrano L, de la Paz MLp (2005) The Amyloid Stretch Hypothesis: Recruiting Proteins toward the Dark Side. Proc Natl Acad Sci U S A 102: 16672–16677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Teng PK, Eisenberg D (2009) Short Protein Segments Can Drive a Non-Fibrillizing Protein into the Amyloid State. Prot Eng Des Sel 22: 531–536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Dobson CM (1999) Protein Misfolding, Evolution and Disease. Trends Biochem Sci 24: 329–332. [DOI] [PubMed] [Google Scholar]
  • 38. von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, et al. (2000) Assembly of Tau Protein into Alzheimer Paired Helical Filaments Depends on a Local Sequence Motif (306VQIVYK311) Forming β Structure. Proc Natl Acad Sci U S A 97: 5129–5134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Thompson A, White AR, McLean C, Masters CL, Cappai R, et al. (2000) Amyloidogenicity and Neurotoxicity of Peptides Corresponding to the Helical Regions of PrPC. Journal of Neurosci Res 62: 293–301. [DOI] [PubMed] [Google Scholar]
  • 40. Wootton JC (1994) Sequences with Unusual Amino Acid Compositions. Curr opin struct biol 4: 413–421. [Google Scholar]
  • 41. Wootton JC (1994) Non-Globular Domains in Protein Sequences: Automated Segmentation Using Complexity Measures. Comput Chem 18: 269–285. [DOI] [PubMed] [Google Scholar]
  • 42. Wootton JC, Federhen S (1993) Statistics of Local Complexity in Amino Acid Sequences and Sequence Databases. Comput Chem 17: 149–163. [Google Scholar]
  • 43. Wang X, Zhang S, Zhang J, Huang X, Xu C, et al. A Large Intrinsically Disordered Region in SKIP and Its Disorder-Order Transition Induced by PPIL1 Binding Revealed by NMR. J Biol Chem 285: 4951–4963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Pedersen JS, Christensen G, Otzen DE (2004) Modulation of S6 Fibrillation by Unfolding Rates and Gatekeeper Residues. J Mol Biol 341: 575–588. [DOI] [PubMed] [Google Scholar]
  • 45. Schlessinger A, Punta M, Yachdav G (2009) Improved Disorder Prediction by Combination of Orthogonal Approaches. PLOS ONE 4: e4433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Lise S, Jones DT (2005) Sequence Patterns Associated with Disordered Regions in Proteins. Proteins 58: 144–150. [DOI] [PubMed] [Google Scholar]
  • 47. Romero P, Obradovic Z, Li X, Garner E, Brown C, et al. (2001) Sequence Complexity of Disordered Protein. Proteins 42: 38–48. [DOI] [PubMed] [Google Scholar]
  • 48. Danzer KM, Ruf WP, Putcha P, Joyner D, Hashimoto T, et al. Heat-Shock Protein 70 Modulates Toxic Extracellular α-Synuclein Oligomers and Rescues Trans-Synaptic Toxicity. FASEB J 25: 326–336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Huntley M, Golding G (2002) Simple Sequences Are Rare in the Protein Data Bank. Proteins 48: 134–140. [DOI] [PubMed] [Google Scholar]
  • 50. Magrane M, Consortium U (2011) UniProt Knowledgebase: A Hub of Integrated Protein Data. Database 2011: bar009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Fukuchi S, Sakamoto S, Nobe Y, Murakami SD, Amemiya T, et al. (2012) IDEAL: Intrinsically Disordered Proteins with Extensive Annotations and Literature. Nuc Acids Res 40: D507–D511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Bemporad F (2006) Sequence and Structural Determinants of Amyloid Fibril Formation. Acc Chem Res 39: 620–627. [DOI] [PubMed] [Google Scholar]
  • 53. Caflisch A (2006) Computational Models for the Prediction of Polypeptide Aggregation Propensity. Curr Opin Chem Biol 10: 437–444. [DOI] [PubMed] [Google Scholar]
  • 54. Chiti F, Dobson C (2006) Protein Misfolding, Functional Amyloid, and Human Disease. Annu Rev Biochem 75: 333–366. [DOI] [PubMed] [Google Scholar]
  • 55. Fernandez-Escamilla A, Rousseau F, Schymkowitz J, Serrano L (2004) Prediction of Sequence-Dependent and Mutational Effects on the Aggregation of Peptides and Proteins. Nat Biotechnol 22: 1302–11306. [DOI] [PubMed] [Google Scholar]
  • 56. Maurer-Stroh S, Debulpaep M, Kuemmerer N, de la Paz ML, Martins IC, et al. (2010) Exploring the Sequence Determinants of Amyloid Structure Using Position-Specific Scoring Matrices. Nat Meth 7: 237–242. [DOI] [PubMed] [Google Scholar]
  • 57. Shin SW, Kim SM (2005) A New Algorithm for Detecting Low-Complexity Regions in Protein Sequences. Bioinformatics 21: 160–170. [DOI] [PubMed] [Google Scholar]
  • 58. Albà MM, Laskowski RA, Hancock JM (2002) Detecting Cryptically Simple Protein Sequences Using the SIMPLE Algorithm. Bioinformatics 18: 672–678. [DOI] [PubMed] [Google Scholar]
  • 59. Raghava G (2000) APSSP2: Protein Secondary Structure Prediction Using Nearest Neighbor and Neural Network Approach. CASP 4: 75–76. [Google Scholar]
  • 60. Jones D (1999) Protein secondary Structure Prediction Based on Position-Specific Scoring Matrices. J Mol Biol 292: 195–202. [DOI] [PubMed] [Google Scholar]
  • 61. Dosztanyi Z, Csizmok V, Tompa P, Simon I (2005) IUPred: Web Server for the Pre-Diction of Intrinsically Unstructured Regions of Proteins Based on Estimated Energy Content. Bioinformatics 21: 3433–3434. [DOI] [PubMed] [Google Scholar]
  • 62. Schultz Jr, Milpetz F, Bork P, Ponting CP (1998) SMART, A Simple Modular Architecture Research Tool: Identification of Signaling Domains. Proc Natl Acad Sci 95: 5857–5864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Schad E, Kalmar L, Tompa P (2013) Exon-Phase Symmetry and Intrinsic Structural Disorder Promote Modular Evolution in the Human Genome. Nuc Acids Res 41: 4409–4422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Frousios KK, Iconomidou VA, Karletidi CM, Hamodrakas SJ (2009) Amyloidogenic Determinants Are Usually Not Buried. BMC Struct Biol 9: 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Tian J, Wu NF, Guo J, Fan YL (2009) Prediction of Amyloid Fibril-Forming Segments Based on a Support Vector Machine. BMC Bioinformatics 10: 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Garbuzynskiy SO, Lobanov MY, Galzitskaya OV (2010) FoldAmyloid: A Method of Prediction of Amyloidogenic Regions from Protein Sequence. Bioinformatics 26: 326–332. [DOI] [PubMed] [Google Scholar]
  • 67. Yoon S, Welsh WJ (2004) Detecting Hidden Sequence Propensity for Amyloid Fibril Formation. Protein Sci 13: 2149–2160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Tartaglia GG, Cavalli A, Pellarin R, Caflisch A (2005) Prediction of Aggregation Rate and Aggregation-Prone Segments in Polypeptide Sequences. Protein Sci 14: 2723–2734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Pawar AP, DuBay KF, Zurdo J, Chiti F, Vendruscolo M, et al. (2005) Prediction of “Aggregation-Prone” and “Aggregation-Susceptible” Regions in Proteins Associated with Neurodegenerative Diseases. J Mol Biol 350: 379–392. [DOI] [PubMed] [Google Scholar]
  • 70. Thompson M, Sievers S, Karanicolas J, Ivanova M, Baker D, et al. (2006) The 3D Profile Method for Identifying Fibril-Forming Segments of Proteins. Proc Natl Acad Sci U S A 103: 4074–4078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X, et al. (2007) AGGRESCAN: A Server for the Prediction and Evaluation of “Hot Spots” Of Aggregation in Polypeptides. BMC Bioinformatics 8: 17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Zhang Z, Chen H, Lai L (2007) Identification of Amyloid Fibril-Forming Segments Based on Structure and Residue-Based Statistical Potential. Bioinformatics 23: 2218–2225. [DOI] [PubMed] [Google Scholar]
  • 73. Tartaglia GG, Pawar AP, Campioni S, Dobson CM, Chiti F, et al. (2008) Prediction of Aggregation-Prone Regions in Structured Proteins. J Mol Biol 380: 425–436. [DOI] [PubMed] [Google Scholar]
  • 74. Galzitskaya OV, Garbuzynskiy SO, Lobanov MY (2007) Expected Packing Density Allows Prediction of Both Amyloidogenic and Disordered Regions in Protein Chains. J Phys Condens Matter 19: 285225. [Google Scholar]
  • 75. Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L (2004) A Comparative Study of the Relationship Between Protein Structure and β-Aggregation in Globular and Intrinsically Disordered Proteins. J Mol Biol 342: 345–353. [DOI] [PubMed] [Google Scholar]
  • 76. Calamai M, Chiti F, Dobson CM (2005) Amyloid Fibril Formation Can Proceed from Different Conformations of a Partially Unfolded Protein. Biophys J 89: 4201–4210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Monsellier E, Ramazzotti M, Taddei N, Chiti F (2008) Aggregation Propensity of the Human Proteome. PLOS Comput Biol 4: 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Huang K, Maiti NC, Phillips NB, Carey PR, Weiss MA (2006) Structure-Specific Effects of Protein Topology on Cross-β Assembly: Studies of Insulin Fibrillation. Biochemistry 45: 10278–10293. [DOI] [PubMed] [Google Scholar]
  • 79. Mohan A, Oldfield CJ, Radivojac P, Vacic V, Cortese MS, et al. (2006) Analysis of Molecular Recognition Features (MoRFs). J Mol Biol 362: 1043–1059. [DOI] [PubMed] [Google Scholar]
  • 80. Vacic V, Oldfield CJ, Mohan A, Radivojac P, Cortese MS, et al. (2007) Characterization of Molecular Recognition Features, MoRFs, and Their Binding Partners. J Proteome Res 6: 2351–2366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Disfani FM, Hsu WL, Mizianty MJ, Oldfield CJ, Xue B, et al. (2012) MoRFpred, a Computational Tool for Sequence-based Prediction and Characterization of Short Disorder-to-order Transitioning Binding Regions in Proteins. Bioinformatics 28: I75–I83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Dosztanyi Z, Meszaros B, Simon I (2009) ANCHOR: Web Server for Predicting Protein Binding Regions in Disordered Proteins. Bioinformatics 25: 2745–2746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Karlin S, Burge C (1996) Trinucleotide Repeats and Long Homopeptides in Genes and Proteins Associated with Nervous System Disease and Development. Proc Natl Acad Sci U S A 93: 1560–1565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Al-Ali H, Rieger ME, Seldeen KL, Harris TK, Farooq A, et al. (2010) Biophysical Characterization Reveals Structural Disorder in the Developmental Transcriptional Regulator LBH. Biochem Biophys Res Commun 391: 1104–1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Angarica VE, Ventura S, Sancho J (2013) Discovering Putative Prion Sequences in Complete Proteomes Using Probabilistic Representations of Q/N-rich Domains. BMC Genomics 14: 316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Du Z (2011) The Complexity and Implications of Yeast Prion Domains. Prion 5: 311–316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Halfmann R, Alberti S, Krishnan R, Lyle N, O'Donnell CW, et al. (2011) Opposing Effects of Glutamine and Asparagine Govern Prion Formation by Intrinsically Disordered Proteins. Mol Cell 43: 72–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Malinovska L, Kroschwald S, Alberti S (2013) Protein Disorder, Prion Propensities, and Self-Organizing Macromolecular Collectives. Biochim Biophys Acta Proteins Proteomics 1834: 918–931. [DOI] [PubMed] [Google Scholar]
  • 89. Mohan A, Uversky VN, Radivojac P (2009) Influence of Sequence Changes and Environment on Intrinsically Disordered Proteins. PLOS Comput Biol 5: e1000497. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Text S1

Stable distribution function. Details of the statistical distribution function applied to AR/LCR length/content distribution.

(DOCX)

Table S1

DisProt human proteins. Protein name, database IDs and AR/LCR content measured by IUPred are listed. Last two columns in the tables display the number of ARs found within 15 residues from the C- and N- terminal of the protein sequence and these are marked as ‘C’ and ‘N’ column, respectively.

(XLSX)

Table S2

DisProt nonhuman proteins. Protein name, database IDs and AR/LCR content measured by IUPred are listed. Last two columns in the tables display the number of ARs found within 15 residues from the C- and N- terminal of the protein sequence and these are marked as ‘C’ and ‘N’ column, respectively.

(XLSX)

Table S3

IDEAL human proteins. Protein name, database IDs and AR/LCR content measured by IUPred are listed. Last two columns in the tables display the number of ARs found within 15 residues from the C- and N- terminal of the protein sequence and these are marked as ‘C’ and ‘N’ column, respectively.

(XLSX)

Table S4

IDEAL nonhuman proteins. Protein name, database IDs and AR/LCR content measured by IUPred are listed. Last two columns in the tables display the number of ARs found within 15 residues from the C- and N- terminal of the protein sequence and these are marked as ‘C’ and ‘N’ column, respectively.

(XLSX)

Table S5

The t-test results for the comparison of different group of proteins. The p-values were obtained using inbuilt program in Microsoft Office Excel.

(XLSX)

Table S6

AR sequences and their positions in DisProt proteins. UniProt and DisProt IDs and the AR/LCR percentages in respective proteins are given.

(XLSX)


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES